71 filings from 5 registrants · 2008–2020 · latest filed May 13, 2020
Reported on its behalf
$29.4M
every LD-2 on file
Its own filed spend
$27.8M
lobbying for itself
Fees to outside firms
$1.6M
across every firm on file
Spend over time
Every filing period on record, as reported. One column per filed period — a period with no column is a period with no filing, not a zero.
Basis · Amendments and terminations supersede the original report for the same registrant, client and period, so a revised quarter is counted once at its latest filed value. Registration-only filings carry no activity money and are excluded from these totals.
Who lobbies for them
Every outside firm that has filed on this client's behalf, by fees reported.
This record groups every filed spelling of the client's name into one entity, so "MERCK & CO., INC." and "MERCK & CO INC" read as the same company. The grouping is the client's normalized name — organizations that file under genuinely different names appear separately. Handle: allergan-usa-inc.
Reading this · LD-2 reports a hired firm's fee and a registrant's reported expenses on separate lines and never both on one filing, so the two lists above are different quantities and are ranked separately rather than against each other. Firm names link to their own record as the firms chapter lands.
CPT
47 filings
$27.8M on those filings
Budget/Appropriations
BUD
39 filings
$23.3M on those filings
Taxation/Internal Revenue Code
TAX
39 filings
$19.4M on those filings
Medical/Disease Research/Clinical Labs
MED
28 filings
$15.8M on those filings
Pharmacy
PHA
27 filings
$20.4M on those filings
Trade (domestic/foreign)
TRD
17 filings
$12.3M on those filings
Telecommunications
TEC
17 filings
$11.7M on those filings
Labor Issues/Antitrust/Workplace
LBR
6 filings
$570K on those filings
Foreign Relations
FOR
4 filings
$2.3M on those filings
Disaster Planning/Emergencies
DIS
2 filings
$1.3M on those filings
Note · A filing names one to several issue areas and reports a single dollar figure for the period, so the same money appears beside every issue that filing declares. The dollar column is therefore spend on filings that named this issue — it is not a split of the total, and these figures sum above it. Filing counts do not double-count.
8 filingsthrough 2014
H.R. 672113th CongressPrescription Drug Abuse Prevention and Treatment Act of 20138 filingsthrough 2014
S. 214113th CongressPreserve Access to Affordable Generics Act8 filingsthrough 2014
S. 348113th CongressPrescription Drug Abuse Prevention and Treatment Act of 20138 filingsthrough 2014
S. 504113th CongressFAIR Generics Act8 filingsthrough 2014
H.R. 1065112th CongressPill Mill Crackdown Act of 20117 filingsthrough 2012
H.R. 1249112th CongressLeahy-Smith America Invents Act7 filingsthrough 2012
H.R. 1316112th CongressStop Oxy Abuse Act of 20117 filingsthrough 2012
H.R. 1483112th CongressDrug Safety Enhancement Act of 20117 filingsthrough 2012
S. 23112th CongressAmerica Invents Act7 filingsthrough 2012
S. 27112th CongressPreserve Access to Affordable Generics Act7 filingsthrough 2012
S. 296112th CongressPreserving Access to Life-Saving Medications Act7 filingsthrough 2012
H.R. 1260111th CongressNamed in the filings; no matching bill record on file.7 filingsthrough 2010
How these are found · Bill references are extracted from the free-text activity description each filing writes, then matched to the Congress in session that filing year. A reference we can't match to a bill on file is still shown, unlinked — we cite what the filing said rather than guess at what it meant. Naming a bill is not a position on it: LD-2 records that a client lobbied on the bill, never which side.
Zachary WilliamsForbes-Tate
11 filingsthrough 2015
Elizabeth GreerForbes-TateCovered position: Chief of Staff, Rep. Allen Boyd11 filingsthrough 2015
Jeffrey ForbesForbes-TateCovered position: Staff Director, Senate Finance Committee ; ; Chief of Staff, Senator Max Baucus ; ; Deputy Asst, Special Asst, Deputy Director EOP11 filingsthrough 2015
Daniel M HarderAllergan USA, Inc.Covered position: Legislative Director - Congressman Mike Bishop; Legislative Assistant - Congressman Mike Bishop; Staff Assistant/Clerk - House Committee on Ways and Means.10 filingsthrough 2020
James M. FentonAllergan USA, Inc.10 filingsthrough 2015
